SHAWNA REED: Open Payments
NPI 1154863199 · VALPARAISO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,172 in 48 payments from 13 companies in 2025. Trend: 2023 $1,015 · 2024 $1,364 · 2025 $1,172
Food & beverage: $1,060Education: $111
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 3 | $182 |
| Teva Pharmaceuticals USA, Inc. | 5 | $163 |
| Lundbeck LLC | 8 | $138 |
| E.R. Squibb & Sons, L.L.C. | 5 | $112 |
| Alkermes, Inc. | 5 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $84 |
| Vanda Pharmaceuticals Inc. | 4 | $82 |
| Gilead Sciences, Inc. | 1 | $80 |
| Otsuka America Pharmaceutical, Inc. | 4 | $73 |
| Neurocrine BioSciences, Inc. | 4 | $71 |
Products named: Azstarys, ABILIFY MAINTENA, COBENFY, CAPLYTA, FANAPT, ARISTADA, INGREZZA, REXULTI.
Industry payments across IN — which companies pay providers there.
